Nisa Investment Advisors
KALV

Nisa Investment Advisors’s KalVista Pharmaceuticals KALV Stock Holding History

Nisa Investment Advisors’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102K Hold
5,076
– – ﹤0.01% 1416
2025
Q4 		$82K Buy
5,076
+519
+11% +$6.87K ﹤0.01% 1492
2025
Q3 		$55.5K Hold
4,557
– – ﹤0.01% 1600
2025
Q2 		$51.5K Hold
4,557
– – ﹤0.01% 1582
2025
Q1 		$52.6K Buy
4,557
+218
+5% +$2.23K ﹤0.01% 1578
2024
Q4 		$36.8K Sell
4,339
-26
-0.6% -$269 ﹤0.01% 1767
2024
Q3 		$50.5K Sell
4,365
-15
-0.3% -$189 ﹤0.01% 1643
2024
Q2 		$51.6K Buy
4,380
+29
+0.7% +$338 ﹤0.01% 1658
2024
Q1 		$51.6K Buy
4,351
+12
+0.3% +$160 ﹤0.01% 1648
2023
Q4 		$53.2K Hold
4,339
– – ﹤0.01% 1622
2023
Q3 		$41.8K Hold
4,339
– – ﹤0.01% 1777
2023
Q2 		$39.1K Buy
4,339
+1,240
+40% +$11.4K ﹤0.01% 1834
2023
Q1 		$24K Hold
3,099
– – ﹤0.01% 1955
2022
Q4 		$21K Buy
+3,099
New +$16.6K ﹤0.01% 2046
2021
Q3 		– Sell
-2,400
Closed -$58 – 2315
2021
Q2 		$58 Buy
+2,400
New +$62.8K ﹤0.01% 1894

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nisa Investment Advisors's KALV Position: Q1 2026 in Review

Nisa Investment Advisors held its KalVista Pharmaceuticals (KALV) position steady in Q1 2026 at 5,076 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

Nisa Investment Advisors first reported a position in KALV in Q2 2021 and has held it in 15 quarters since. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • Nisa Investment Advisors held 5,076 shares of KalVista Pharmaceuticals worth $102K as of Q1 2026.
  • Nisa Investment Advisors left its KalVista Pharmaceuticals share count unchanged in Q1 2026.
  • KalVista Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1416 holding.
  • Nisa Investment Advisors first reported a position in KalVista Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
  • 183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.